GMAN Newsletter – December 2015

  Vol.1 Issue¬†8 December¬† 2015   Four Treatments Approved in the US This Year This year, the US Food and Drug Administration (FDA) approved four new myeloma drugs, three of which were approved just last month. Most recently approved was Empliciti (elotuzumab), a monoclonal antibody developed by Bristol-Myers Squibb and AbbVie, for use in […]